Replies to post #323274 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

Was it a way to document the progress of the IP knowing PPHM BOD,King and the R&D were going bye bye?

wook

[north40000]

JBM's a/k/a surfacing as an author may account for why we did not see him since AACR2017 maybe longer ago than that...SITC 2016.

The book makes a good marketing tool...a collection of the trials, both pre-clinical as well as clinical. I think Dover Press has been around since my graduate school days...I can remember soft-cover texts.

I like the idea of a "Sunrise" history also in preparation...we may see a detailed history the likes of which we have not seen before, confidential disclosure agreements permitting.

[4OurRetirement]

Seems Like That DovePress PDF Should Be Mailed/Emailed/Faxed/etc...

not only members of the BOD (in case they aren't aware of this info) but also to heads of other companies that might be interested in PS technology and perhaps have been too focused on their own pipelines and may not have considered bavituximab, betabodies, or other things in our pipeline like exosomes, cancer blood tests, etc.

Not just BP's either, think broader. Perhaps sending this info to groups like Bill & Melinda Gates Foundation, Alphabet Inc (Google's Mother Company), etc., etc., etc...

Since we were told at the stockholders meeting that there doesn't seem to be a lot of interest, perhaps they aren't knocking on enough doors... after all their strengths are in cdmo manufacturing now!

It's not like we can sell the IP for them, but perhaps we can send out info regarding the IP to contacts that might make a difference. Like, would any financial news organizations be interested in stockholders feeling their leaders are apparently failing to put any value on our IP???

Any proactive helpful thoughts to help think out of the box in breathing life back in to the IP before it is given away for pennies???

Thanks in advance & Glta StockHOLDERS!